Artificial intelligence analysis of CCNG1 expression in tumors: A novel biomarker in development for anti-CCNG1 targeted therapy
Gordon, Erlinda Maria, Omelchenko, Nadezhda, Eid, Caroline, Jeffrey, Samantha, Shekhovtsova, Zhanna, Suryamohan, Kushal, Younesi, Elan, Ahari, Amir, Chawla, Neal Shiv, Brigham, Don Arlen, Morse, Michael, Chawla, Sant P.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Interim results of a phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma
Chawla, Neal Shiv, Omelchenko, Nadezhda, Younesi, Elan, Valencia, Chrysler, Ahari, Amir, Moradkhani, Ania, Chua, Victoria, Brigham, Don, Chawla, Sant P., Gordon, Erlinda Maria
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Results of SOC-2082 phase 2 study using metronomic gemcitabine, doxorubicin and docetaxel plus nivolumab as second/third-line therapy for advanced sarcoma
Omelchenko, Nadezhda, Chawla, Neal Shiv, Makrievski, Stefan, Leao De Melo, Guilherme, Valencia, Chrysler, Ahari, Amir, Moradkhani, Ania, Chua, Victoria, Quon, Doris, Brigham, Don Arlen, Chawla, Sant P., Gordon, Erlinda Maria
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Prevalence of dietary modification and supplement use in patients with metastatic renal cell carcinoma (mRCC)
Ebrahimi, Hedyeh, Battle, Dena, Zengin, Zeynep Busra, Dizman, Nazli, Meza, Luis A, Castro, Daniela V., Govindarajan, Ameish, Mercier, Benjamin D., Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Liu, Sandy, Vaishampayan, Ulka N., Staehler, Michael D., Pal, Sumanta Monty
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
A phase 2 study using ipilimumab, nivolumab, and trabectedin for previously untreated metastatic soft tissue sarcoma
Gordon, Erlinda Maria, Chua, Victoria S., Kim, Ted T., Chawla, Neal Shiv, Brigham, Don Arlen, Bhuiyan, Ishrat, Agulnik, Mark, Chow, Warren Allen, Chawla, Sant P.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Evolution of the functionality of microbial communities in patients with metastatic renal cell carcinoma (mRCC) receiving cabozantinib (cabo)/nivolumab (nivo) with or without CBM588: A randomized clinical trial
Ebrahimi, Hedyeh, Meza, Luis A, Lee, Keehoon, Malhotra, Jasnoor, Alcantara, Marice, Zengin, Zeynep Busra, Dizman, Nazli, Hsu, Joann, Llamas-Quitiquit, Marian, Castro, Daniela V., Mercier, Benjamin D., Barragan-Carrillo, Regina, Chawla, Neal Shiv, Li, Xiaochen, Liu, Sandy, Chehrazi-Raffle, Alex, Dorff, Tanya B., Frankel, Paul Henry, Tripathi, Abhishek, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Clinical and molecular characterization of urothelial (UC) vs. small cell carcinoma (SCC) of the urinary tract
Chawla, Neal Shiv, Mercier, Benjamin D., Govindarajan, Ameish, Li, Xiaochen, Castro, Daniela V., Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Zang, Peter D., LeVee, Alexis Ann, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, Salgia, Nicholas, Chehrazi-Raffle, Alex, Dorff, Tanya B., Pal, Sumanta Kumar, Tripathi, Abhishek
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Adherence to ASCO Language of Respect (LoR) guidelines in urothelial carcinoma (UC) abstracts at the 2023 ASCO Annual Meeting
Castro, Daniela V., Mercier, Benjamin D., Zugman, Miguel, Li, Xiaochen, Barragan-Carrillo, Regina, Wong, Megan Hoikei, Chan, Ethan, Faridi, Amber, Goud, Jaya, Paul, Trishita, Dukkipati, Akasha, Patel, Jalen, Paul, Teebro, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Prowell, Tatiana Michelle, Florez, Narjust, Dizman, Nazli, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Impact of insurance payer status (IS) on practice patterns and overall survival (OS) in patients (pts) with metastatic urothelial carcinoma (mUC)
Mercier, Benjamin D., Tripathi, Nishita, Govindarajan, Ameish, Gebrael, Georges, Narang, Arshit, Li, Xiaochen, Castro, Daniela V., Chehrazi-Raffle, Alex, Dizman, Nazli, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Hsu, Joann, Bergerot, Cristiane Decat, Barragan-Carrillo, Regina, Zengin, Zeynep Busra, Meza, Luis A, Pal, Sumanta Kumar, Agarwal, Neeraj, Tripathi, Abhishek
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Association between thymectomy and incidence of renal cell carcinoma (RCC)
Barragan-Carrillo, Regina, Ebrahimi, Hedyeh, Chawla, Neal Shiv, Salgia, Nicholas, Castro, Daniela V., Chehrazi-Raffle, Alex, Dizman, Nazli, Hsu, Joann, Meza, Luis A, Zengin, Zeynep Busra, LeVee, Alexis Ann, Tripathi, Abhishek, Dorff, Tanya B., Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Eilber, Karyn, Dallas, Kai, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC)
Barragan-Carrillo, Regina, Chawla, Neal Shiv, Salgia, Nicholas, Meza, Luis A, Zengin, Zeynep Busra, Li, Xiaochen, Dizman, Nazli, Ebrahimi, Hedyeh, Hsu, Joann, Castro, Daniela V., Mercier, Benjamin D., Dorff, Tanya B., Tripathi, Abhishek, Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Chehrazi-Raffle, Alex, Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
A phase I trial to evaluate the biologic effect of CBM588 ( Clostridium butyricum ) in combination with cabozantinib plus nivolumab for patients with metastatic renal cell carcinoma (mRCC)
Meza, Luis A, Malhotra, Jasnoor, Zengin, Zeynep Busra, Dizman, Nazli, Hsu, Joann, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Muddasani, Ramya, Govindarajan, Ameish, Castro, Daniela V., Dorff, Tanya B., Lyou, Yung, Frankel, Paul Henry, Pal, Sumanta K.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Characteristics associated with common reasons to pursue genomic profiling among patients with metastatic genitourinary cancers
Malhotra, Jasnoor, Philip, Errol James, Govindarajan, Ameish, Salgia, Sabrina, Meza, Luis A, Zengin, Zeynep Busra, Muddasani, Ramya, Chawla, Neal Shiv, Castro, Daniela, Chehrazi-Raffle, Alex, Dizman, Nazli, Bergerot, Paulo Gustavo, Hsu, Joann, Dorff, Tanya B., Pal, Sumanta K., Bergerot, Cristiane Decat
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Changes in perception of immunotherapy over time among patients with advanced genitourinary cancers
Malhotra, Jasnoor, Philip, Errol James, Govindarajan, Ameish, Meza, Luis A, Zengin, Zeynep Busra, Salgia, Sabrina, Muddasani, Ramya, Chawla, Neal Shiv, Castro, Daniela, Chehrazi-Raffle, Alex, Dizman, Nazli, Bergerot, Paulo Gustavo, Hsu, Joann, Dorff, Tanya B., Pal, Sumanta K., Bergerot, Cristiane Decat
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial
Ebrahimi, Hedyeh, Meza, Luis A., Lee, Keehoon, Malhotra, Jasnoor, Alcantara, Marice, Zengin, Zeynep Busra, Dizman, Nazli, Govindarajan, Ameish, Hsu, Joann, Llamas-Quitiquit, Marian, Chawla, Neal Shiv, Castro, Daniela V., Mercier, Benjamin D., Liu, Sandy, Chehrazi-Raffle, Alex, Dorff, Tanya B., Frankel, Paul Henry, Li, Xiaochen, Pal, Sumanta Kumar, Tripathi, Abhishek
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Association between intra-tumoral microbiome and clinical benefit (CB) from immunotherapy (IO) in patients with metastatic renal cell carcinoma (mRCC)
Meza, Luis A, Choi, Yongwook, Zhang, Jiaming, Dizman, Nazli, Zengin, Zeynep Busra, Ebrahimi, Hedyeh, Barragan-Carrillo, Regina, Hsu, Joann, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Castro, Daniela V., Mercier, Benjamin D, Govindarajan, Ameish, Chan, Agnes, Schork, Nicholas, Byron, Sara A., Pal, Sumanta Kumar
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Spectrum and implications of activating BRAF alterations in advanced prostate cancer (aPC)
Chehrazi-Raffle, Alex, Tukachinsky, Hanna, Schrock, Alexa Betzig, Hwang, Justin, Zengin, Zeynep Busra, Meza, Luis A, Chawla, Neal Shiv, Ebrahimi, Hedyeh, Govindarajan, Ameish, Castro, Daniela V., Rock, Adam, Tripathi, Abhishek, Dorff, Tanya B., Pal, Sumanta Monty, Oxnard, Geoffrey R., Agarwal, Neeraj, Antonarakis, Emmanuel S.
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Radiomic features of renal cell carcinoma primary and metastatic sites as predictors of TERT and BAP1 mutations
Meza, Luis A, Filippov, Aleksandr, Naim, Sohaib, Dizman, Nazli, Chehrazi-Raffle, Alex, Philip, Errol James, Maholtra, Jasnoor, Muddasani, Ramya, Chawla, Neal Shiv, Wong, Chi Wah, Salgia, Sabrina, Karimi, Misagh, Trent, Jeffrey M., Byron, Sara Ann, Chaudhry, Ammar, Pal, Sumanta K.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Transcriptomic profiling identifies genomic markers associated with benefit from stereotactic body radiation therapy (SBRT) in oligoprogressive metastatic renal cell carcinoma (mRCC)
Zengin, Zeynep Busra, Govindarajan, Ameish, Muddasani, Ramya, Salgia, Nicholas, Sayegh, Nicolas, Tripathi, Nishita, Salgia, Sabrina, Meza, Luis A, Zhang, Jiaming, Chawla, Neal Shiv, Chehrazi-Raffle, Alex, Malhotra, Jasnoor, Dizman, Nazli, Hsu, Joann, Castro, Daniela V., Byron, Sara A., Dandapani, Savita V., Pal, Sumanta K.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article